CN104706707A - Antiviral immunity-enhancing ginseng healthcare product - Google Patents
Antiviral immunity-enhancing ginseng healthcare product Download PDFInfo
- Publication number
- CN104706707A CN104706707A CN201310672607.XA CN201310672607A CN104706707A CN 104706707 A CN104706707 A CN 104706707A CN 201310672607 A CN201310672607 A CN 201310672607A CN 104706707 A CN104706707 A CN 104706707A
- Authority
- CN
- China
- Prior art keywords
- fructus
- ginseng
- radix
- health product
- raw material
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- 241000208340 Araliaceae Species 0.000 title claims abstract description 47
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 title claims abstract description 47
- 235000003140 Panax quinquefolius Nutrition 0.000 title claims abstract description 47
- 235000008434 ginseng Nutrition 0.000 title claims abstract description 47
- 230000000840 anti-viral effect Effects 0.000 title claims abstract description 27
- 230000036541 health Effects 0.000 claims description 38
- 239000009609 fructus phyllanthi Substances 0.000 claims description 23
- 239000002994 raw material Substances 0.000 claims description 19
- 230000036737 immune function Effects 0.000 claims description 14
- 241000222336 Ganoderma Species 0.000 claims description 10
- 235000014134 echinacea Nutrition 0.000 claims description 10
- 241000756943 Codonopsis Species 0.000 claims description 7
- 239000000203 mixture Substances 0.000 claims description 5
- 241000258180 Echinacea <Echinodermata> Species 0.000 claims 3
- 239000008280 blood Substances 0.000 abstract description 24
- 210000004369 blood Anatomy 0.000 abstract description 24
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract description 14
- 201000010099 disease Diseases 0.000 abstract description 13
- 230000036772 blood pressure Effects 0.000 abstract description 12
- 230000036039 immunity Effects 0.000 abstract description 10
- 230000007774 longterm Effects 0.000 abstract description 6
- 235000013305 food Nutrition 0.000 abstract description 5
- 210000000056 organ Anatomy 0.000 abstract description 5
- 210000004185 liver Anatomy 0.000 abstract description 4
- 210000003734 kidney Anatomy 0.000 abstract description 3
- 210000004556 brain Anatomy 0.000 abstract description 2
- 210000002216 heart Anatomy 0.000 abstract description 2
- 210000004072 lung Anatomy 0.000 abstract description 2
- 235000000346 sugar Nutrition 0.000 abstract description 2
- 244000241838 Lycium barbarum Species 0.000 abstract 1
- 235000015459 Lycium barbarum Nutrition 0.000 abstract 1
- 235000015468 Lycium chinense Nutrition 0.000 abstract 1
- 240000000249 Morus alba Species 0.000 abstract 1
- 235000008708 Morus alba Nutrition 0.000 abstract 1
- 231100000331 toxic Toxicity 0.000 abstract 1
- 230000002588 toxic effect Effects 0.000 abstract 1
- 239000003814 drug Substances 0.000 description 30
- 230000000694 effects Effects 0.000 description 18
- 235000001727 glucose Nutrition 0.000 description 14
- 206010020772 Hypertension Diseases 0.000 description 12
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 11
- 239000008103 glucose Substances 0.000 description 11
- 238000011282 treatment Methods 0.000 description 9
- 244000133098 Echinacea angustifolia Species 0.000 description 7
- 241000700605 Viruses Species 0.000 description 7
- 238000012360 testing method Methods 0.000 description 7
- 208000007271 Substance Withdrawal Syndrome Diseases 0.000 description 6
- 150000002304 glucoses Chemical class 0.000 description 6
- 208000002672 hepatitis B Diseases 0.000 description 6
- 230000003908 liver function Effects 0.000 description 6
- 235000012054 meals Nutrition 0.000 description 6
- QSHDDOUJBYECFT-UHFFFAOYSA-N mercury Chemical compound [Hg] QSHDDOUJBYECFT-UHFFFAOYSA-N 0.000 description 6
- 229910052753 mercury Inorganic materials 0.000 description 6
- 230000000630 rising effect Effects 0.000 description 6
- 230000003203 everyday effect Effects 0.000 description 4
- 239000000427 antigen Substances 0.000 description 3
- 102000036639 antigens Human genes 0.000 description 3
- 108091007433 antigens Proteins 0.000 description 3
- 239000003795 chemical substances by application Substances 0.000 description 3
- 208000002173 dizziness Diseases 0.000 description 3
- 230000002708 enhancing effect Effects 0.000 description 3
- 238000011156 evaluation Methods 0.000 description 3
- 239000000284 extract Substances 0.000 description 3
- 230000006870 function Effects 0.000 description 3
- 239000007788 liquid Substances 0.000 description 3
- 238000000034 method Methods 0.000 description 3
- 239000006187 pill Substances 0.000 description 3
- 231100000614 poison Toxicity 0.000 description 3
- 235000014347 soups Nutrition 0.000 description 3
- 230000001225 therapeutic effect Effects 0.000 description 3
- 230000035922 thirst Effects 0.000 description 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 3
- 206010010144 Completed suicide Diseases 0.000 description 2
- 206010011224 Cough Diseases 0.000 description 2
- 206010062717 Increased upper airway secretion Diseases 0.000 description 2
- 241000699670 Mus sp. Species 0.000 description 2
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 2
- 230000036528 appetite Effects 0.000 description 2
- 235000019789 appetite Nutrition 0.000 description 2
- 230000017531 blood circulation Effects 0.000 description 2
- 210000001124 body fluid Anatomy 0.000 description 2
- 239000010839 body fluid Substances 0.000 description 2
- 230000037396 body weight Effects 0.000 description 2
- 229940126678 chinese medicines Drugs 0.000 description 2
- 230000007423 decrease Effects 0.000 description 2
- 235000013399 edible fruits Nutrition 0.000 description 2
- LNTHITQWFMADLM-UHFFFAOYSA-N gallic acid Chemical compound OC(=O)C1=CC(O)=C(O)C(O)=C1 LNTHITQWFMADLM-UHFFFAOYSA-N 0.000 description 2
- 235000013402 health food Nutrition 0.000 description 2
- 241000411851 herbal medicine Species 0.000 description 2
- 201000001421 hyperglycemia Diseases 0.000 description 2
- 208000015181 infectious disease Diseases 0.000 description 2
- 206010022437 insomnia Diseases 0.000 description 2
- 238000007689 inspection Methods 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 231100000682 maximum tolerated dose Toxicity 0.000 description 2
- 210000003205 muscle Anatomy 0.000 description 2
- 230000035772 mutation Effects 0.000 description 2
- 231100000957 no side effect Toxicity 0.000 description 2
- 231100000252 nontoxic Toxicity 0.000 description 2
- 230000003000 nontoxic effect Effects 0.000 description 2
- 208000026435 phlegm Diseases 0.000 description 2
- 239000002574 poison Substances 0.000 description 2
- 230000001737 promoting effect Effects 0.000 description 2
- 238000010791 quenching Methods 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- 230000003238 somatosensory effect Effects 0.000 description 2
- 238000001179 sorption measurement Methods 0.000 description 2
- 238000005728 strengthening Methods 0.000 description 2
- 235000018553 tannin Nutrition 0.000 description 2
- 229920001864 tannin Polymers 0.000 description 2
- 239000001648 tannin Substances 0.000 description 2
- 239000003440 toxic substance Substances 0.000 description 2
- 230000003612 virological effect Effects 0.000 description 2
- 235000001674 Agaricus brunnescens Nutrition 0.000 description 1
- 208000017667 Chronic Disease Diseases 0.000 description 1
- 244000119298 Emblica officinalis Species 0.000 description 1
- 235000015489 Emblica officinalis Nutrition 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 208000004930 Fatty Liver Diseases 0.000 description 1
- 206010019708 Hepatic steatosis Diseases 0.000 description 1
- 206010019799 Hepatitis viral Diseases 0.000 description 1
- 208000031226 Hyperlipidaemia Diseases 0.000 description 1
- 102000014150 Interferons Human genes 0.000 description 1
- 108010050904 Interferons Proteins 0.000 description 1
- 240000000599 Lentinula edodes Species 0.000 description 1
- 235000001715 Lentinula edodes Nutrition 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 208000001431 Psychomotor Agitation Diseases 0.000 description 1
- 206010037660 Pyrexia Diseases 0.000 description 1
- 206010038743 Restlessness Diseases 0.000 description 1
- 206010041349 Somnolence Diseases 0.000 description 1
- 206010047513 Vision blurred Diseases 0.000 description 1
- 208000031971 Yin Deficiency Diseases 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 231100000460 acute oral toxicity Toxicity 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- 238000013019 agitation Methods 0.000 description 1
- 238000010171 animal model Methods 0.000 description 1
- 230000001093 anti-cancer Effects 0.000 description 1
- 230000000721 bacterilogical effect Effects 0.000 description 1
- 230000003796 beauty Effects 0.000 description 1
- 210000000988 bone and bone Anatomy 0.000 description 1
- 210000001185 bone marrow Anatomy 0.000 description 1
- 230000000747 cardiac effect Effects 0.000 description 1
- 230000001413 cellular effect Effects 0.000 description 1
- 230000001684 chronic effect Effects 0.000 description 1
- 208000020832 chronic kidney disease Diseases 0.000 description 1
- 235000009508 confectionery Nutrition 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 230000002950 deficient Effects 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- 230000035487 diastolic blood pressure Effects 0.000 description 1
- 206010013023 diphtheria Diseases 0.000 description 1
- 239000002552 dosage form Substances 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 238000001647 drug administration Methods 0.000 description 1
- 230000002526 effect on cardiovascular system Effects 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 238000003912 environmental pollution Methods 0.000 description 1
- 210000003414 extremity Anatomy 0.000 description 1
- 206010016256 fatigue Diseases 0.000 description 1
- 208000010706 fatty liver disease Diseases 0.000 description 1
- 239000000835 fiber Substances 0.000 description 1
- 238000007667 floating Methods 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 229940074391 gallic acid Drugs 0.000 description 1
- 235000004515 gallic acid Nutrition 0.000 description 1
- 230000002068 genetic effect Effects 0.000 description 1
- 230000007674 genetic toxicity Effects 0.000 description 1
- 231100000025 genetic toxicology Toxicity 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 229910001385 heavy metal Inorganic materials 0.000 description 1
- 230000002440 hepatic effect Effects 0.000 description 1
- 208000006454 hepatitis Diseases 0.000 description 1
- 231100000283 hepatitis Toxicity 0.000 description 1
- 230000002443 hepatoprotective effect Effects 0.000 description 1
- 235000008216 herbs Nutrition 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 230000010354 integration Effects 0.000 description 1
- 229940079322 interferon Drugs 0.000 description 1
- 210000000936 intestine Anatomy 0.000 description 1
- 230000001788 irregular Effects 0.000 description 1
- 210000003127 knee Anatomy 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 230000036244 malformation Effects 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 239000002398 materia medica Substances 0.000 description 1
- 238000007479 molecular analysis Methods 0.000 description 1
- 210000000653 nervous system Anatomy 0.000 description 1
- 239000002547 new drug Substances 0.000 description 1
- 230000001717 pathogenic effect Effects 0.000 description 1
- 235000017807 phytochemicals Nutrition 0.000 description 1
- 229930000223 plant secondary metabolite Natural products 0.000 description 1
- 206010036067 polydipsia Diseases 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 230000003449 preventive effect Effects 0.000 description 1
- 230000005180 public health Effects 0.000 description 1
- 208000008128 pulmonary tuberculosis Diseases 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 210000002345 respiratory system Anatomy 0.000 description 1
- 210000002784 stomach Anatomy 0.000 description 1
- 230000035488 systolic blood pressure Effects 0.000 description 1
- 230000001256 tonic effect Effects 0.000 description 1
- 231100000167 toxic agent Toxicity 0.000 description 1
- 231100000027 toxicology Toxicity 0.000 description 1
- 230000005760 tumorsuppression Effects 0.000 description 1
- 201000001862 viral hepatitis Diseases 0.000 description 1
- 210000001835 viscera Anatomy 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The invention discloses an antiviral immunity-enhancing ginseng healthcare product, which is composed of ginseng, wolfberry, mulberry, and the like. The formula is reasonable and scientific, and can act on human organs such as heart, brain, kidney, lung, liver, and the like. The traditional Chinese herbals in the formula can be eaten as food, are safe and harmless, do not have any side or toxic effect for long term use, have mild herbal properties, can strengthen the immunity and regulate the human blood pressure, blood sugar, and blood fat, and is capable of treating and preventing some normal diseases on human organs.
Description
Technical field
The present invention relates to a kind of Chinese medicine and healthcare field, be specifically related to one and strengthen immune ginseng health product for antiviral.
Background technology
Due to the fast development of modern society, the life-span of people generally extends; Along with, the degree of concern of people to own health also improves constantly, the many factors such as environmental pollution, food pollution, inherited genetic factors are led, operating pressure, infection cause popualtion healthy level to decline, but pursue healthy health and and then longevity be mankind's targets since ancient times, many people are considered as the maximum value of life.How in conjunction with modern medicine, the newest fruits of chemistry to Chinese herbal medicine molecular studies, prepare Chinese medicine health care product, the health of enhancement crowd can be safeguarded, correct the chronic disease of the sub-health state of crowd, treatment crowd, long-term taking is free from side effects, playing and illly to cure the disease, illly anosisly all can prolong raw object, is the target of the world of medicine's long-term struggle.
Immunologic function is most important to health, and viral disease disease such as flu, viral hepatitis etc. cause by virus, and the present mankind still do not find good radical cure method, Chinese traditional treatment virus disease is difficult to there is radical cure possibility, mainly due to composition complex in Chinese medicine, also very complicated on the impact of immune function of human body, be difficult to grasp, be difficult to quantize, when the traditional Chinese medical science is write a prescription, can not from accurately strengthening immune function of human body, prescription change is fast, pile up Chinese medicine simply, be called and distinguish disease, actually poor effect.The anxious phytochemical achievement in research to be combined of traditional Chinese medical science subject, all chronic deficient property disease treatments, to strengthen immunologic function for principle, carry out prescription, raise revolutionary new page.
Summary of the invention
Antiviral is the object of the present invention is to provide to strengthen immune ginseng health product.
The present invention adopts following technical scheme:
A kind of antiviral strengthens immune ginseng health product, it is characterized in that being made up of the raw material of following weight portion: Radix Ginseng 1-10, Fructus Phyllanthi 10-30.
Described antiviral strengthens immune ginseng health product, it is characterized in that being made up of the raw material of following weight portion: Radix Ginseng 1-5, Fructus Phyllanthi 10-20.
Described antiviral strengthens immune ginseng health product, it is characterized in that described Radix Ginseng strengthens immunologic function composition such as Fructus Lycii by Radix Codonopsis or Echinacea or other and substitutes.
Described antiviral strengthens immune ginseng health product, to it is characterized in that in raw material one of eight or combination in any also containing following weight portion: Fructus Lycii 10-30, Fructus Ligustri Lucidi 5-20, Fructus Mori 10-30, Radix Cirsii Japonici 5-15, Radix Salviae Miltiorrhizae 5-15, Ganoderma 5-15, Radix Codonopsis 5-15, Echinacea 1-10.
Described antiviral strengthens immune ginseng health product, to it is characterized in that in raw material also containing following weight portion: Fructus Lycii 10-20, Fructus Ligustri Lucidi 5-15, Fructus Mori 10-20, Radix Cirsii Japonici 5-10.
Described antiviral strengthens immune ginseng health product, to it is characterized in that in raw material also containing following weight portion: Fructus Lycii 10-20, Fructus Ligustri Lucidi 5-15, Fructus Mori 10-20, Radix Cirsii Japonici 5-10, Radix Salviae Miltiorrhizae 5-10.
Described antiviral strengthens immune ginseng health product, to it is characterized in that in raw material also containing following weight portion: Fructus Lycii 10-15, Fructus Ligustri Lucidi 8-12, Fructus Mori 15-20.
Described antiviral strengthens immune ginseng health product, to it is characterized in that in raw material also containing following weight portion: Fructus Lycii 10-15, Fructus Ligustri Lucidi 8-12, Fructus Mori 15-20, Radix Cirsii Japonici 5-10, Echinacea 1-5.
Described antiviral strengthens immune ginseng health product, to it is characterized in that in raw material also containing following weight portion: Fructus Lycii 10-15, Fructus Ligustri Lucidi 8-12, Fructus Mori 15-20, Radix Cirsii Japonici 5-10, Ganoderma 5-12.
Described antiviral strengthens immune ginseng health product, to it is characterized in that in raw material also containing following weight portion: Fructus Lycii 10-15, Fructus Ligustri Lucidi 8-12, Fructus Mori 15-20, Ganoderma 5-12.
In formula of the present invention, Fructus Phyllanthi is the medicinal plants of health care and disease cure, and its fruit has nearly bimillennial history in China as Chinese medicine among the people.As far back as Han dynasty, raise floating " foreign body will " and special discussion is had to the medical value of emblic.That records in later Tang Materia Medica, " Hainan book on Chinese herbal medicine " is definitely detailed." Chinese medicine voluminous dictionary " is illustrated as " reduce phlegm, give birth to dregs, cough-relieving, detoxify, cure cold heating, cough, pharyngalgia, diphtheria, restlessness and fever with thirst " the medical value of Fructus Phyllanthi.The body-building labor effect that ancient medicine great master Li Shizhen (1518-1593 A.D.) has affirmed fully Fructus Phyllanthi in Compendium of Material Medica to be had " clothes are made light of one's life by commiting suicide for a long time, prolong life long-living ".Tens, whole world country or nationality use Fructus Phyllanthi in the conventional medicament system of oneself.Fructus Phyllanthi have prevent and treat hypertension, hyperlipidemia, defying age, protect the liver, stomach invigorating, beauty treatment, fat-reducing, row's metallic poison, diabetes, the therapeutic efficiency such as anti-various viruses.
Radix Ginseng is the king of BAICAO, the enhancing immunity effect of tool, containing Radix Ginseng in the Herba Sidae Rhombifoliae soup of Japan, refreshing medicine is called by Japanese at Japanese Herba Sidae Rhombifoliae soup, treatment hepatitis virus is effective, and curative effect, higher than Western medicine such as interferon, is taken Herba Sidae Rhombifoliae soup E antigen and turned out cloudy and reach 90%, grind and trace it to its cause, be that wherein Radix Ginseng serves crux effect.
The application is substantially square, adopt people to participate in Fructus Phyllanthi collocation, extremely there is innovation, intend the national new drug of application or functional health care food, Radix Ginseng enhancing immunity, Fructus Phyllanthi can strengthen immunity on the one hand, and tannin tannin, gallic acid on the other hand wherein containing sufficient content, can have adsorption to various virus, play antiviral object, Papillary, can cure the viral diseases such as hepatitis B, effective equally to cold virus.
The application respectively organizes prescription, still completely applicable for Healthy People, can strengthen immunity, blood pressure lowering, blood fat reducing, blood sugar lowering, Adsorption of Heavy Metals etc., useful health, long-term taking, can prevent sudden change, life lengthening.
The application can arrange in pairs or groups other functional component equally, the requirement of these functional components is, must can strengthen immune function of human body, or do not have an impact as Radix Cirsii Japonici, Herba Taraxaci to immunologic function, and immune function of human body can not be lowered, general heat-clearing and toxic substances removing is all reduce immunologic function, must adopt cautiously.These compositions strengthening immunologic function generally comprise: Fructus Lycii, Fructus Ligustri Lucidi, Fructus Mori, Radix Codonopsis, Echinacea, Rhizoma Coptidis, Folium Mahoniae, Radix Salviae Miltiorrhizae, Radix Cirsii Japonici, Herba Taraxaci etc.
Fructus Lycii is Chinese nation's tonic since ancient times, the flat effect with the liver and the kidney tonifying of its sweet in the mouth, property, says and " take hard muscles and bones for a long time, make light of one's life by commiting suicide not old, resistance to cold and summer-heat in Compendium of Material Medica." traditional Chinese medical science commonly use it treating hepatic and renal YIN deficiency, soreness of the waist and knees, dizziness, forgetful, dizzy, the many tear of blurred vision, quench one's thirst, the disease such as seminal emission.Modern pharmacology research confirms Radix Ginseng scalable body's immunity, can effectively grow and cell mutation, have the effect of the aspects such as slow down aging, anti-fatty liver, adjusting blood lipid and blood glucose by Tumor suppression.Therapeutic efficiency is had for Patients with Chronic Renal Disease.
Fructus Mori sour in the mouth, cold nature, have improve body immunity, the effect such as dry is dispelled in YIN nourishing of enriching blood, promoting the production of body fluid to quench thirst, intestine moistening.
Ganoderma has inhibitory action to nervous system, and blood circulation has blood pressure lowering and strengthens the effect of cardiac contractile force, has phlegm-dispelling functions to respiratory system, in addition, also has hepatoprotective, improves immunologic function, antibacterially waits effect.
Radix Cirsii Japonici clearing away heat and cooling blood, has no side effect, and is used for anticancer, and treatment pulmonary tuberculosis has good effect.
Radix Salviae Miltiorrhizae energy blood circulation promoting and blood stasis dispelling, wherein all containing there being mutation functional component, can help the cardiovascular and cerebrovascular vessel health of protecting human body.
Fructus Ligustri Lucidi can strengthen immunologic function, can help and protect health.
In the present invention, Radix Cirsii Japonici can by Folium Mahoniae, Rhizoma Coptidis, in the removing pathogenic heat from blood and toxic substance from the body Chinese medicines such as Herba Taraxaci any one or arbitrarily multiple combination to replace or part replaces, Radix Salviae Miltiorrhizae is replaced by other blood-activating and stasis-removing or part replaces, Fructus Ligustri Lucidi, Fructus Mori, Fructus Lycii can by other as Rhizoma Polygonati, Rhizoma Polygonati Odorati etc. are enriched blood the similar Chinese medicine of yin nourishing, QI invigorating, the mushroom of tonifying YANG Chinese medicine and increase immunity replaces as Lentinus Edodes or part replaces, Fructus Phyllanthi can by Fructus Chebulae, Fructus Terminaliae Billericae, Fructus Canarii replaces or part replaces, when replacing or partly replace, dosage can correspondingly increase, more than replace all belonging to inventive concept, all belong to and invade patent right of the present invention.
The present invention is entirely just through studying intensively, reasonably combined, for each organ such as the heart, brain, kidney, lung, liver of human body, medication all targetedly, and scientific formulation, these Chinese medicines all belong to integration of edible and medicinal herbs food, safety non-toxic, long-term taking, has no side effect, and mild in medicine property and, can immunity be promoted, suppress and eliminate virus and bacteriological infection, regulating human blood-pressure, blood glucose, blood fat, to the existing health care preventive effect of the multiple common disease of each organ of crowd, also there is certain therapeutical effect.
Detailed description of the invention
Embodiment 1:
Antiviral of the present invention strengthens immune ginseng health product, is made up of the raw material of following weight portion (gram), and on the basis of Fructus Phyllanthi, Radix Ginseng, various collocation, all can realize object of the present invention, and each prescription is as follows:
1, Radix Ginseng 1-3, Fructus Phyllanthi 10-20.
2, Radix Codonopsis 5-10, Fructus Phyllanthi 10-20.
3, Echinacea 1-5, Fructus Phyllanthi 10-20.
4, Radix Ginseng 1-3, Fructus Phyllanthi 15-20, Fructus Lycii 10-20, Fructus Ligustri Lucidi 5-10, Fructus Mori 10-20, Radix Cirsii Japonici 5-10, Radix Salviae Miltiorrhizae 5-105, Ganoderma 10-15, Radix Codonopsis 5-10, Echinacea 1-3.
5, Radix Ginseng 1-3, Fructus Phyllanthi 10-20, Fructus Lycii 10-15, Fructus Ligustri Lucidi 5-10, Fructus Mori 15-20, Radix Cirsii Japonici 5-10.
6, Radix Ginseng 1-3, Fructus Phyllanthi 10-20, Fructus Lycii 10-20, Fructus Ligustri Lucidi 5-10, Fructus Mori 10-15, Radix Cirsii Japonici 5-10, Radix Salviae Miltiorrhizae 5-10.
7, Radix Ginseng 1-3, Fructus Phyllanthi 10-20, Fructus Lycii 10-15, Fructus Ligustri Lucidi 8-12, Fructus Mori 15-20.
8, Radix Ginseng 1-3, Fructus Phyllanthi 10-20, Fructus Lycii 10-15, Fructus Ligustri Lucidi 8-12, Fructus Mori 15-20, Radix Cirsii Japonici 5-10, Echinacea 1-5.
9, Radix Ginseng 1-3, Fructus Phyllanthi 10-20, Fructus Lycii 10-15, Fructus Ligustri Lucidi 8-12, Fructus Mori 15-20, Radix Cirsii Japonici 5-10, Ganoderma 5-12.
10, Radix Ginseng 1-3, Fructus Phyllanthi 10-20, Fructus Lycii 10-15, Fructus Ligustri Lucidi 8-12, Fructus Mori 15-20, Ganoderma 5-12.
Decocting potion every day, also can make other dosage form.
One, zoopery functional effect checking of the present invention:
Above 1-10 prescription, carry out safety poison by Ministry of Public Health " health food inspection and assessment technical specification " (version in 2003) evaluation methodology and learn evaluation test, result is as follows:
(1) acute oral toxicity test: the maximum tolerated dose (MTD) of sample to male and female white mice is all greater than 20000mg/kg;
(2) three genetic toxicity tests: mice bone marrow micronucleus, sperm malformation test, Ames result of the test are feminine gender;
(3) 30 days feeding trials: experimental session, experimental animal growing state is good, each dosage group body weight, weightening finish, food utilization, routine blood indexes, blood biochemistry index, organ weights and internal organs/body weight ratio and histological indications compared with matched group, equal no significant difference.
Safety toxicology result of the test show sample safety non-toxic.
Get the powder in the embodiment of the present invention 1, according to the evaluation methodology of " health food inspection and assessment technical specification " (version in 2003), carry out animal function test, this sample has enhancing cellular immune function, strengthens body fluid immunity function.
Two, prescription 5 water extract of the present invention, for crowd treat checking as follows:
Grandson, man, 46 years old, closely feel thirsty, polydipsia over the past half year, health is become thin gradually, tired out, drowsiness, measure fasting glucose 11.6 mmol/l, two hours blood glucoses are 14.5 mmol/l after meal, dose a patient with medicine of the present invention, every day potion, every agent liquid medicine decocts twice, taking January is a course for the treatment of, after two months, survey its fasting glucose 6.1 mmol/l, 2 hours blood glucoses are 8.6 mmol/l after meal.Allow its following the service bimester with consolidate curative effect.
Lin, female, 59 years old, nearly half a year, somatosensory was tired, lost weight, companion's poor appetite, irritated, insomnia, and dry stool sometimes, the dark tongue of light red tongue is white, deep and hesitant pulse.Fasting glucose time medical: fasting glucose 12.3 mmol/l, two hours blood glucoses are 15.5 mmol/l after meal, dose a patient with medicine of the present invention, every day potion, every agent liquid medicine decocts twice, and taking January is a course for the treatment of, after two months, survey its fasting glucose 6.4 mmol/l, 2 hours blood glucoses are 8.8mmol/l after meal.Allow its following the service bimester with consolidate curative effect.
Wang, female, 65 years old, nearly half a year, somatosensory was tired, lost weight, companion's poor appetite, agitation, insomnia, fasting glucose time medical: fasting glucose 11.3 mmol/l, two hours blood glucoses are 13.8 mmol/l after meal, and dose a patient with medicine of the present invention, every day potion, every agent liquid medicine decocts twice, and taking January is a course for the treatment of, after two months, survey its fasting glucose 6.0 mmol/l, 2 hours blood glucoses are 8.1mmol/l after meal.Allow its following the service bimester with consolidate curative effect.
Three, prescription 6 water extract of the present invention, for crowd treat checking as follows:
Lee, female, 45 years old, suffers from hypertension 8 years, blood pressure high pressure 150 millimeters of high mercury column at ordinary times, low pressure 100 millimeters of high mercury column.Take hypertension pill normal after, drug withdrawal rebounds rising immediately.Use medicine of the present invention, after taking 2 months, the normal 130/90mmHg of Measure blood pressure, drug withdrawal after one month Measure blood pressure still without rising, recover.
Zhang, female, 56 years old, suffers from hypertension 4 years, blood pressure high pressure 155 millimeters of high mercury column at ordinary times, low pressure 110 millimeters of high mercury column.Take hypertension pill normal after, drug withdrawal rebounds rising immediately.Use medicine of the present invention, after taking 2 months, the normal 125/95mmHg of Measure blood pressure, drug withdrawal after one month Measure blood pressure still without rising, recover.
Wang, female, 65 years old, suffers from hypertension 10 years, blood pressure high pressure 160 millimeters of high mercury column at ordinary times, low pressure 110 millimeters of high mercury column.Take hypertension pill normal after, drug withdrawal rebounds rising immediately.Use medicine of the present invention, after taking 2 months, the normal 140/95mmHg of Measure blood pressure, drug withdrawal after one month Measure blood pressure still without rising, recover.
In certain, man, 84 years old, I was fat, dizzy distending pain all day, and body is stranded limb acid, and heavy fiber crops are unable, and health check-up blood pressure 150/110 mmHg, blood fat are high.With drug administration of the present invention 5 months, health was normal, all transference cures.Check that blood pressure, blood fat are all normal.
Four, prescription 1 water extract of the present invention, for crowd treat checking as follows:
Lee, man, 29 years old, hepatitis B, was detected as great three positive, the course of disease 15 years, and liver function is normal, and in many ways seek medical advice, invalid, take medicine of the present invention, day takes potion, and within 6 months, detect, be small three positive, liver function is normal.
Grandson, female, 37 years old, hepatitis B, was detected as small three positive, the course of disease 18 years, and liver function is normal, and in many ways seek medical advice, invalid, take medicine of the present invention, day takes potion, within 6 months, detected, and five indices is negative entirely, and liver function is normal; Following the service medicine of the present invention 6 months, surface antibody is positive, recovery from illness.
Zhao, man 32 years old, hepatitis B, is detected as great three positive, the course of disease 11 years, normal during liver function, time and irregular variation is large, in many ways seek medical advice, invalid, take medicine of the present invention, take potion day, within 6 months, detect, be small three positive, liver function is normal.
Prescription 1-10 of the present invention, all through checking, all have good effect to hyperglycemia, hypertension, hepatitis B, long-term taking, people's spirit is vigorous, and muscle power is strong, and complexion is good.Reduce by 30% for effect with blood glucose, the minimum effective percentage of each prescription to hyperglycemia reaches more than 80%, is up to 89%; Be effectively with systolic pressure, the arbitrary decline 20mmHg of diastolic pressure, each prescription is minimum reaches more than 80% to hypertension effective percentage; Each prescription is to hepatitis B great three positive patient, and E antigen is turned out cloudy and reached more than 90%, and surface antigen is turned out cloudy and reached more than 70%, above all with 6 months statistics of taking medicine.
Claims (10)
1. antiviral strengthens an immune ginseng health product, it is characterized in that being made up of the raw material of following weight portion: Radix Ginseng 1-10, Fructus Phyllanthi 10-30.
2. antiviral according to claim 1 strengthens immune ginseng health product, it is characterized in that being made up of the raw material of following weight portion: Radix Ginseng 1-5, Fructus Phyllanthi 10-20.
3. antiviral according to claim 1 and 2 strengthens immune ginseng health product, it is characterized in that described Radix Ginseng strengthens immunologic function composition such as Fructus Lycii by Radix Codonopsis or Echinacea or other and substitutes.
4. antiviral according to claim 1 strengthens immune ginseng health product, to it is characterized in that in raw material one of eight or combination in any also containing following weight portion: Fructus Lycii 10-30, Fructus Ligustri Lucidi 5-20, Fructus Mori 10-30, Radix Cirsii Japonici 5-15, Radix Salviae Miltiorrhizae 5-15, Ganoderma 5-15, Radix Codonopsis 5-15, Echinacea 1-10.
5. antiviral according to claim 4 strengthens immune ginseng health product, to it is characterized in that in raw material also containing following weight portion: Fructus Lycii 10-20, Fructus Ligustri Lucidi 5-15, Fructus Mori 10-20, Radix Cirsii Japonici 5-10.
6. antiviral according to claim 4 strengthens immune ginseng health product, to it is characterized in that in raw material also containing following weight portion: Fructus Lycii 10-20, Fructus Ligustri Lucidi 5-15, Fructus Mori 10-20, Radix Cirsii Japonici 5-10, Radix Salviae Miltiorrhizae 5-10.
7. antiviral according to claim 4 strengthens immune ginseng health product, to it is characterized in that in raw material also containing following weight portion: Fructus Lycii 10-15, Fructus Ligustri Lucidi 8-12, Fructus Mori 15-20.
8. antiviral according to claim 4 strengthens immune ginseng health product, to it is characterized in that in raw material also containing following weight portion: Fructus Lycii 10-15, Fructus Ligustri Lucidi 8-12, Fructus Mori 15-20, Radix Cirsii Japonici 5-10, Echinacea 1-5.
9. antiviral according to claim 4 strengthens immune ginseng health product, to it is characterized in that in raw material also containing following weight portion: Fructus Lycii 10-15, Fructus Ligustri Lucidi 8-12, Fructus Mori 15-20, Radix Cirsii Japonici 5-10, Ganoderma 5-12.
10. antiviral according to claim 4 strengthens immune ginseng health product, to it is characterized in that in raw material also containing following weight portion: Fructus Lycii 10-15, Fructus Ligustri Lucidi 8-12, Fructus Mori 15-20, Ganoderma 5-12.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201310672607.XA CN104706707A (en) | 2013-12-12 | 2013-12-12 | Antiviral immunity-enhancing ginseng healthcare product |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201310672607.XA CN104706707A (en) | 2013-12-12 | 2013-12-12 | Antiviral immunity-enhancing ginseng healthcare product |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN104706707A true CN104706707A (en) | 2015-06-17 |
Family
ID=53406752
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201310672607.XA Withdrawn CN104706707A (en) | 2013-12-12 | 2013-12-12 | Antiviral immunity-enhancing ginseng healthcare product |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN104706707A (en) |
Cited By (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN106343571A (en) * | 2016-08-27 | 2017-01-25 | 桂林七星粉业有限责任公司 | Processing technique of mulberry health-care food for improving immunity |
| CN108142941A (en) * | 2016-12-03 | 2018-06-12 | 河北以岭医药研究院有限公司 | A kind of health food containing ganoderma lucidum and preparation method thereof |
| CN109588705A (en) * | 2018-12-20 | 2019-04-09 | 韦德举 | A kind of selenium-rich ginseng Chinese-wolfberry nutritive food and preparation method thereof adjusting inferior health |
| CN112057549A (en) * | 2020-04-04 | 2020-12-11 | 杨京润 | Preparation for reducing blood sugar, blood fat and virus and preparation method thereof |
| CN112826077A (en) * | 2020-12-31 | 2021-05-25 | 黄泽昊 | Medicinal and edible composition for enhancing human body resistance |
| CN113616732A (en) * | 2021-08-31 | 2021-11-09 | 大姚华盛饮料食品有限责任公司 | Formula and preparation method of ginseng-olive tablet |
Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1704085A (en) * | 2004-06-04 | 2005-12-07 | 成都地奥制药集团有限公司 | Pharmaceutical composition with immunoregulation function and method for preparing the same |
| CN1965883A (en) * | 2006-11-21 | 2007-05-23 | 华南理工大学 | Anti-hepatitis B compound formulation, preparation process and application thereof |
| CN101856430A (en) * | 2009-04-08 | 2010-10-13 | 周艳 | Green tonic lucid ganoderma (three immortals) cream for preventing sub-health and preparation method thereof |
-
2013
- 2013-12-12 CN CN201310672607.XA patent/CN104706707A/en not_active Withdrawn
Patent Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1704085A (en) * | 2004-06-04 | 2005-12-07 | 成都地奥制药集团有限公司 | Pharmaceutical composition with immunoregulation function and method for preparing the same |
| CN1965883A (en) * | 2006-11-21 | 2007-05-23 | 华南理工大学 | Anti-hepatitis B compound formulation, preparation process and application thereof |
| CN101856430A (en) * | 2009-04-08 | 2010-10-13 | 周艳 | Green tonic lucid ganoderma (three immortals) cream for preventing sub-health and preparation method thereof |
Non-Patent Citations (1)
| Title |
|---|
| 吉守祥等: "余甘子等28种藏药提取物体外抗乙型肝炎病毒的实验研究", 《中药材》 * |
Cited By (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN106343571A (en) * | 2016-08-27 | 2017-01-25 | 桂林七星粉业有限责任公司 | Processing technique of mulberry health-care food for improving immunity |
| CN108142941A (en) * | 2016-12-03 | 2018-06-12 | 河北以岭医药研究院有限公司 | A kind of health food containing ganoderma lucidum and preparation method thereof |
| CN109588705A (en) * | 2018-12-20 | 2019-04-09 | 韦德举 | A kind of selenium-rich ginseng Chinese-wolfberry nutritive food and preparation method thereof adjusting inferior health |
| CN112057549A (en) * | 2020-04-04 | 2020-12-11 | 杨京润 | Preparation for reducing blood sugar, blood fat and virus and preparation method thereof |
| CN112826077A (en) * | 2020-12-31 | 2021-05-25 | 黄泽昊 | Medicinal and edible composition for enhancing human body resistance |
| CN113616732A (en) * | 2021-08-31 | 2021-11-09 | 大姚华盛饮料食品有限责任公司 | Formula and preparation method of ginseng-olive tablet |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN104706707A (en) | Antiviral immunity-enhancing ginseng healthcare product | |
| CN104001035A (en) | Trichosanthis Radix and Radix Puerariae-containing traditional Chinese medicinal preparation for treating type 2 diabetes mellitus | |
| CN102462834A (en) | Medicinal composition for controlling blood sugar of diabetic | |
| CN103719672A (en) | Medical rice gruel capable of nourishing Qi and blood | |
| CN105395706A (en) | Health care product for diabetes | |
| CN104587302A (en) | Traditional Chinese medicine preparation for treating acute appendicitis | |
| CN104705634A (en) | Lucid ganoderma healthcare product for protecting health | |
| CN104740079A (en) | Phyllanthus emblica health-care traditional Chinese medicine composition | |
| CN103800689A (en) | Traditional Chinese medicine composition for treating diabetes mellitus | |
| CN104687032A (en) | Health caring echinacea health product | |
| CN103933280A (en) | Traditional Chinese medicine composition for treating PCI (percutanecus coronary intervention) postoperative angina of phlegm-obstructing heart vessel type coronary heart disease and application thereof | |
| CN104706813A (en) | Mulberry-glossy privet fruit health composition | |
| CN103230457A (en) | Traditional Chinese medicine composition for treating viral myocarditis and preparation method and use thereof | |
| CN103393938B (en) | Traditional Chinese medicine composition for reducing blood sugar | |
| CN106072556A (en) | For health food regulating blood glucose and preparation method thereof | |
| CN105168892A (en) | Chinese herbal preparation for treating hypoglycemia and preparing method of Chinese herbal preparation | |
| CN104706815A (en) | Wolfberry-pseudo-ginseng health composition | |
| CN104306847A (en) | Six-ingredient qi-tonifying capsule and preparation process thereof | |
| CN104258295A (en) | Traditional Chinese medicine decoction for treating lymphoma | |
| CN104688999A (en) | Chinese herbal preparation for immunity enhancement | |
| CN104758578A (en) | Traditional Chinese medicine composition for treating palpitation | |
| CN104705637A (en) | A Chinese wolfberry and mulberry health-care combination | |
| CN104225387A (en) | Traditional Chinese medicine composition for treating damp-heat blocked type diabetes feet | |
| CN103495022A (en) | Traditional Chinese medicine for adjuvant therapy of aids | |
| CN103989954A (en) | Traditional Chinese medicine preparation for treating iron-deficiency anemia |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| WW01 | Invention patent application withdrawn after publication |
Application publication date: 20150617 |
|
| WW01 | Invention patent application withdrawn after publication |